STOCK TITAN

FMR LLC holds 10.2% of XOMA Royalty (XOMA) after Schedule 13G/A amendment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

XOMA ROYALTY CORPORATION ownership update: FMR LLC reports beneficial ownership of 1,268,506.14 shares of common stock, representing 10.2% of the class as of 02/27/2026. The filing also notes that Fidelity Contrafund held 773,332 shares, or 6.2%, as of the same date.

The schedule is an amendment (No. 5) and identifies filings and powers of attorney authorizing the submission; Exhibit 99 and related exhibits are referenced for subsidiary and agreement details.

Positive

  • None.

Negative

  • None.

Insights

FMR LLC holds a double‑digit stake in XOMA Royalty as of 02/27/2026.

FMR LLC is listed as beneficial owner of 1,268,506.14 shares, equal to 10.2% of common stock as of 02/27/2026. This identifies a meaningful passive holding that requires disclosure under Schedule 13G/A rules.

The filing names Abigail P. Johnson in a dispositive role and discloses that Fidelity Contrafund holds 773,332 shares (6.2%), per Item 6. Future filings or exhibits (Exhibit 99) may show whether sales, transfers, or voting arrangements alter this stake.

Amendment clarifies beneficial ownership and references authority documents.

The schedule cites powers of attorney incorporated by reference and an exhibit for a 13d-1(k)(1) agreement, indicating delegated filing authority and potential coordination among affiliates. The filing attributes sole dispositive power to the named filers.

Stakeholders should note the filing type (Schedule 13G/A amendment) signals a reported passive or qualifying ownership status rather than an active takeover filing; subsequent amendments could change disclosure if ownership or intent changes.






02/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:03/05/2026
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:03/05/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What stake does FMR LLC report in XOMA (XOMA)?

FMR LLC reports beneficial ownership of 1,268,506.14 shares, equal to 10.2% of XOMA common stock as of 02/27/2026. This amount is shown on the amended Schedule 13G/A (Amendment No. 5).

Does Abigail P. Johnson appear in the XOMA Schedule 13G/A?

Yes. Abigail P. Johnson is named with sole dispositive power over 1,268,506.14 shares, matching the 10.2% beneficial position reported as of 02/27/2026.

What other large holder is disclosed in this XOMA filing?

The filing states that Fidelity Contrafund held 773,332 shares, or 6.2%, of XOMA common stock as of 02/27/2026, reported under Item 6 regarding holdings on behalf of another person.

What exhibits or authorizations are referenced in the XOMA Schedule 13G/A?

The amendment references Exhibit 99 for a 13d-1(k)(1) agreement and incorporates powers of attorney by reference (Exhibit 24 filings dated January 2023) authorizing the signatures on the filing.

Does this Schedule 13G/A indicate an acquisition intent for XOMA?

No intent statement is included; the filing is an amended Schedule 13G/A reporting beneficial ownership of 10.2% as of 02/27/2026. It does not state a change in intent or a Schedule 13D takeover filing.
XOMA Royalty Corporation

NASDAQ:XOMAO

View XOMAO Stock Overview

XOMAO Rankings

XOMAO Latest News

XOMAO Latest SEC Filings

XOMAO Stock Data

1.60M
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE